ECE2009 Poster Presentations Paediatric Endocrinology (18 abstracts)
1Department of Growth and Reproduction, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 2Norwegian Oping Control Laboratory, Aker University Hospital, Oslo, Norway.
Testosterone (T) is excreted in urine as water soluble glucuronidated and sulphatated conjugates. The ability to glucuronidate T and other steroids depends on a number of different glucuronidases (UGT) of which UGT2B17 is essential. The aim of the study was to evaluate the influence of UGT2B17 genotypes on urinary excretion of androgen metabolites in pubertal boys.
Study design: A clinical study of 116 healthy boys aged 8 to 19 years. UGT2B17 genotyping was performed using quantitative PCR. Serum FSH, LH, T, estradiol (E2) and SHBG were analysed by immunoassays, and urinary levels of androgen metabolites were quantitated by gas chromatography/mass spectrometry in all subjects.
Results: Ten out of 116 subjects (9%) presented with a homozygote deletion of the UGT2B17 gene (del/del), while 52 and 54 boys were hetero- or homozygous carriers of the UGT2B17 gene (del/ins and ins/ins), respectively. None of the reproductive hormones were affected by UGT2B17 genotype. In all subjects, mean urinary T/E ratio was 1.56 (1.14 (S.D.); 0.16.9 (range)) and unaffected by age or pubertal stage. Subjects with homozygous deletions of UGT2B17 had significantly lower urinary levels of T, and 5α- and 5β-Androstanediol. Mean urinary T/E was significantly reduced in del/del subjects (0.29 (0.30); 0.11.0 (range), P<0.0001).
Conclusion: In pubertal boys, a common homozygous deletion in the UGT2B17 gene strongly affected urinary excretion pattern of androgen metabolites, but did not influence circulating androgen levels.